A new mononuclear cobalt(III) complex, [Co(HL1)2]Cl (1), derived from the reduced Schiff base 2,2'-((ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol (H2L1), and a new dinuclear cobalt(III) complex, [Co2(L2)2]∆2H2O (2), derived from the reduced Schiff base 6,6'-(2-hydroxypropane-1,3-diyl)bis(azanediyl)bis(methylene)bis(2-bromo-4-chlorophenol)… Click to show full abstract
A new mononuclear cobalt(III) complex, [Co(HL1)2]Cl (1), derived from the reduced Schiff base 2,2'-((ethane-1,2-diylbis(azanediyl))bis(methylene))diphenol (H2L1), and a new dinuclear cobalt(III) complex, [Co2(L2)2]∆2H2O (2), derived from the reduced Schiff base 6,6'-(2-hydroxypropane-1,3-diyl)bis(azanediyl)bis(methylene)bis(2-bromo-4-chlorophenol) (H2L2), were synthesized and characterized by infrared and electronic spectroscopy, and single crystal X-ray diffraction techniques. The ligands were synthesized first, and then bound to the Co(III) centre. Compound 1 contains a mononuclear [Co(HL1)2]+ cation and a chloride anion. The cationic moiety possesses crystallographic inversion center symmetry. Compound 2 contains a dinuclear [Co2(L2)2] molecule and two water hydrate molecules. The Co atoms in the complexes are in octahedral coordination. Both complexes showed potential antimicrobial activity.
               
Click one of the above tabs to view related content.